POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 84 filers reported holding POINT BIOPHARMA GLOBAL INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $584,552 | +2.1% | 87,639 | +38.7% | 0.00% | – |
| Q2 2023 | $572,375 | +136.6% | 63,176 | +89.8% | 0.00% | – |
| Q1 2023 | $241,960 | -67.1% | 33,282 | -67.0% | 0.00% | – |
| Q4 2022 | $734,519 | +265.4% | 100,757 | +286.7% | 0.00% | – |
| Q3 2022 | $201,000 | +161.0% | 26,053 | +129.9% | 0.00% | – |
| Q2 2022 | $77,000 | +450.0% | 11,334 | +361.7% | 0.00% | – |
| Q4 2021 | $14,000 | – | 2,455 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,383,029 | $24,594,621 | 4.83% |
| Velan Capital Investment Management LP | 494,136 | $3,592,369 | 3.06% |
| BVF INC/IL | 10,563,748 | $76,798,448 | 2.81% |
| JOHNSON & JOHNSON | 1,000,000 | $7,270,000 | 2.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 952,642 | $6,925,707 | 1.16% |
| PFM Health Sciences, LP | 3,204,790 | $23,298,823 | 1.03% |
| Pier Capital, LLC | 862,736 | $6,272,091 | 0.95% |
| Boxer Capital, LLC | 2,500,000 | $18,175 | 0.89% |
| Deep Track Capital, LP | 2,345,073 | $17,048,681 | 0.70% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 198,477 | $1,442,928 | 0.60% |